Search by Drug Name or NDC
NDC 59762-1005-01 Cabergoline 0.5 mg/1 Details
Cabergoline 0.5 mg/1
Cabergoline is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Greenstone LLC. The primary component is CABERGOLINE.
MedlinePlus Drug Summary
Cabergoline is used to treat hyperprolactinemia (high levels of prolactin, a natural substance that helps breast-feeding women produce milk but can cause symptoms such as infertility, sexual problems, and bone loss in women who are not breast-feeding or men). Cabergoline is in a class of medications called dopamine receptor agonists. It works by decreasing the amount of prolactin in the body.
Related Packages: 59762-1005-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cabergoline
Product Information
| NDC | 59762-1005 |
|---|---|
| Product ID | 59762-1005_fde5cfe8-549f-4b73-ba75-b621b6310eaf |
| Associated GPIs | 30402020000320 |
| GCN Sequence Number | 025738 |
| GCN Sequence Number Description | cabergoline TABLET 0.5 MG ORAL |
| HIC3 | P1F |
| HIC3 Description | PITUITARY SUPPRESSIVE AGENTS |
| GCN | 26051 |
| HICL Sequence Number | 010803 |
| HICL Sequence Number Description | CABERGOLINE |
| Brand/Generic | Generic |
| Proprietary Name | Cabergoline |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cabergoline |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | CABERGOLINE |
| Labeler Name | Greenstone LLC |
| Pharmaceutical Class | Ergolines [CS], Ergot Derivative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA020664 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59762-1005-01 (59762100501)
| NDC Package Code | 59762-1005-1 |
|---|---|
| Billing NDC | 59762100501 |
| Package | 8 TABLET in 1 BOTTLE (59762-1005-1) |
| Marketing Start Date | 2014-09-22 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.6792 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CABERGOLINE 0.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis